MedTrace Logo

Effectiveness of Thoracolumbar Fascia Mobilization and Ultrasound-Guided 5% Dextrose Injection in Chronic Low Back Pain

NCT07241559 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2026-05-07

No results posted yet for this study

Summary

The aim of this study is to investigate the effects of thoracolumbar fascia mobilization and ultrasound-guided thoracolumbar interfascial 5% dextrose injection on pain, range of motion, disability, quality of life, proprioception, and fascial thickness and echogenicity in patients with nonspecific chronic low back pain.

-Primary Objective: The primary objective is to evaluate the effects of these interventions on pain, functional status and range of motion.

-Secondary Objective: The secondary objective is to assess the long-term effects on quality of life, proprioception, fascial thickness, and echogenicity.

Conditions

  • Chronic Low Back Pain

Interventions

DRUG

5% dextrose injection

10 mL of 5% dextrose solution will be injected into the target area.

PROCEDURE

Myofascial Release

Patients in this group will receive thoracolumbar fascia mobilization. A total of six sessions of myofascial release therapy will be administered twice per week for three weeks.

Sponsors & Collaborators

  • Ankara Training and Research Hospital

    collaborator OTHER

  • Ankara City Hospital Bilkent

    lead OTHER

Principal Investigators

  • Büşra ALÇIN, Medical Doctor · Ankara Training and Research Hospital

  • Nida KOÇER NAZLIGÜL, Medical Doctor · Ankara Training and Research Hospital

  • Barış NACIR · Ankara Training and Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2026-04-01
Completion
2026-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07241559 on ClinicalTrials.gov